Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04)

NCT03021291 is registered in ClinicalTrials.gov with Gelesis, Inc. as lead sponsor.

NCT NCT03021291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03021291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04)
Lead sponsor
Gelesis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 25, 2017
Completion date
December 15, 2017
Enrollment
36 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

overweight and obesity